Literature DB >> 1634251

Natural killer (NK) cell activity in human long-term bone marrow cultures (LTBMC): effects of interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF) on the progenitor cells.

E Sitnicka1, M Hansson.   

Abstract

Human bone marrow-derived progenitor cells were studied in a long-term bone marrow culture system (LTBMC) dependent on an autologous stroma cell layer. The establishment of the stromal cell layer was facilitated by using marrow obtained from small pieces of sternum, which was cultured for 4 weeks without addition of exogenous growth factors. After this period, the response of LTBMC to two different cytokines [recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)] was investigated. Our results show proliferation in response to both cytokines and induction of differentiation of cells able to bind IL-2 and/or GM-CSF again. The two cytokines also generate cells responding to rhGM-CSF by colony formation. However, a difference with respect to morphology, phenotype and cytotoxic function of cells in the LTBMC, was noted between the two cytokines. Cells with large granular lymphocyte (LGL) morphology and cytotoxic activity against K562 and Daudi were generated only in the rhIL-2-supplemented LTBMC. This was compatible with a higher frequency of cells expressing the CD56+ phenotype in the IL-2-stimulated LTBMC as compared to the GM-CSF supplemented LTBMC. Our results also demonstrate the existence of a population of myeloid progenitor cells (CD33+) with ability to bind IL-2 in fresh bone marrow (BM).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1634251      PMCID: PMC1421546     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Generation of cytotoxic cells from murine bone marrow by human recombinant IL 2.

Authors:  G C Koo; C L Manyak
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

Review 2.  The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells.

Authors:  D Metcalf
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  Regulation of expression of the interleukin-2 receptor on hematopoietic cells by interleukin-3.

Authors:  M C Birchenall-Sparks; W L Farrar; D Rennick; P L Kilian; F W Ruscetti
Journal:  Science       Date:  1986-07-25       Impact factor: 47.728

4.  rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2.

Authors:  M H Ben Aribia; E Leroy; O Lantz; D Métivier; B Autran; B Charpentier; T Hercend; A Senik
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

5.  Promonocytes have the functional characteristics of natural killer cells.

Authors:  M L Lohmann-Matthes; W Domzig; J Roder
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

6.  Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells).

Authors:  F Shirakawa; Y Tanaka; S Eto; H Suzuki; J Yodoi; U Yamashita
Journal:  J Immunol       Date:  1986-07-15       Impact factor: 5.422

7.  Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level.

Authors:  E Tritarelli; E Rocca; U Testa; G Boccoli; A Camagna; F Calabresi; C Peschle
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

8.  Transplantable progenitors of natural killer cells are distinct from those of T and B lymphocytes.

Authors:  J Hackett; G C Bosma; M J Bosma; M Bennett; V Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

9.  Interleukin 3 is a major negative regulator of the generation of natural killer cells from bone marrow precursors.

Authors:  T Kalland
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

10.  Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.

Authors:  W H Chambers; N L Vujanovic; A B DeLeo; M W Olszowy; R B Herberman; J C Hiserodt
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.